Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
RGT | Sydney | AUD | Delayed | |
MGCLF | OTC Markets | USD | Delayed | |
RGT | London | GBP | Real-time |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Tri-Star Bullish | 1H | 2 | Apr 15, 2024 14:00 | ||
Tri-Star Bullish | 30 | 2 | Apr 15, 2024 14:30 | ||
Tri-Star Bullish | 15 | 2 | Apr 15, 2024 14:30 | ||
Tri-Star Bearish | 1D | 3 | Apr 05, 2024 | ||
Tri-Star Bearish | 5H | 3 | Apr 05, 2024 14:00 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
Sydney | 0.425 | 0.405 | 0.425 | 27,990 | -1.16% | AUD | |||
OTC Markets | 0.270 | 0.000 | 0.000 | 0 | +0.00% | USD | |||
London | 21.00 | 20.00 | 23.00 | 330 | 0.00% | GBP |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Rolls-Royce Holdings | 417.20 | 417.20 | 406.60 | +10.90 | +2.68% | 62.87M | 16:35:59 | ||
IAG | 175.95 | 179.35 | 175.95 | +0.75 | +0.43% | 21.47M | 16:35:59 | ||
Barclays | 192.24 | 193.58 | 190.48 | +3.06 | +1.62% | 76.49M | 16:35:59 | ||
Lloyds Banking | 51.34 | 51.69 | 50.88 | +0.20 | +0.39% | 190.29M | 16:35:59 | ||
Vodafone Group PLC | 69.620 | 70.640 | 69.620 | 0.000 | 0.00% | 150.82M | 16:35:59 | ||
HSBC | 667.70 | 669.60 | 663.80 | +1.20 | +0.18% | 28.45M | 16:35:59 | ||
BP | 523.10 | 530.60 | 521.00 | +0.60 | +0.12% | 51.68M | 16:35:59 | ||
British American Tobacco | 2,360.0 | 2,389.0 | 2,360.0 | 0.0 | 0.00% | 6.43M | 16:35:59 | ||
Legal & General | 253.10 | 255.00 | 251.20 | +2.70 | +1.08% | 16.70M | 16:35:59 | ||
EasyJet | 545.00 | 553.98 | 544.20 | -2.20 | -0.40% | 9.08M | 16:35:59 |
Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review